Ånirban is a Senior Investment Associate at Trill Impact Advisory, focusing on Impact Ventures. He has more than 10 years of professional experience from both life science R&D and pharmaceutical consulting, spanning Europe. 

Before joining Trill Impact, he worked as a management consultant at IQVIA (Financial Institutions practice) in London and at Bionest Partners in Paris. His professional history also includes venture capital experience from emerging health ventures in Stockholm and industry experience from Novo Nordisk in Copenhagen. 

Ånirban holds a Ph.D. in Biomedicine from Lund University and an MBA from HEC Paris, France. He has also performed postdoctoral research work at Karolinska Institutet.